PharmaCorp Rx Inc.
PCRX.V
TSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -261.68% | -67.33% | 175.96% | -64.01% | -189.88% |
Total Depreciation and Amortization | 4.36% | -4.53% | 146.04% | 239.02% | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 50.35% | 96.70% | -179.39% | 17,816.67% | -- |
Change in Net Operating Assets | 110.87% | -137.41% | 255.17% | -216.41% | 2,971.43% |
Cash from Operations | -249.50% | -88.66% | 268.90% | -309.91% | 18.09% |
Capital Expenditure | -8,088.24% | -- | -- | 100.00% | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -594.43% | -2,707.51% | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -12,026.74% | 99.82% | -594.43% | -2,950.75% | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 0.39% | 0.78% | -25.55% | -166.01% | -- |
Issuance of Common Stock | -- | -- | -100.00% | -61.54% | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -3.40% | 3.29% | -100.66% | -61.59% | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -6,838.12% | 100.37% | -376.01% | -75.28% | 10,383.33% |